Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome
Condition(s) studied
Study summary
Observational, multicenter, prospective study aimed at characterizing the gut microbiome in patients with post-infectious irritable bowel syndrome (PI-IBS) using whole genome sequencing (WGS). The study will compare microbiome composition and function between PI-IBS patients and two control groups (post-infectious subjects without irritable bowel syndrome -IBS- and healthy controls), with the goal of identifying reproducible microbial signatures and target taxa associated with disease and symptom severity.
Eligibility
Primary outcome measure(s)
- Identification of microbial signatures discriminating PI-IBS from controls — Baseline up to 30 months (end of study)
Identification of reproducible gut microbiome signatures, including taxonomic and functional profiles, that discriminate patients with post-infectious irritable bowel syndrome (PI-IBS) from control groups using whole genome shotgun sequencing and machine learning approaches.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Digestive Disease Center, Fondazione Policlinico Univesitario A. Gemelli IRCCS | Rome | Italy | Recruiting |
More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07517029 on ClinicalTrials.gov ↗ ← All trials in Italy